Phones in class, a 25-year prescription gone wrong, pickleball's hidden danger, and why your spin class is too loud — four findings hiding in everyday care.
Pain reprocessing therapy produced small but measurable reductions in cross-modal sensory amplification, pointing to a broader neurological signature of chronic back pain than previously recognized.
Navepegritide is described as the first therapy to deliver continuous C-type natriuretic peptide exposure over a weekly dosing interval in eligible pediatric patients.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
What people hear and do not hear can have a direct effect on their balance, according to new research from the New York Eye and Ear Infirmary of Mount Sinai (NYEE).